Sanne Y Smith-Apeldoorn
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 26, 2025
Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.Jolien Ke Veraart, Sanne Y Smith-Apeldoorn, Annemarie van der Meij
|May 12, 2022
The antidepressant effect and safety of non-intranasal esketamine: A systematic review.Sanne Y Smith-Apeldoorn, Maurice Vischjager, Jolien Ke Veraart
|Dec 06, 2021
Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study.Sanne Y Smith-Apeldoorn, Jolien K E Veraart, Henricus G Ruhé
|Dec 01, 2019
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.Sanne Y Smith-Apeldoorn, Jolien K E Veraart, Jeanine Kamphuis
Pageof 1
